Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy

Muscle and Nerve

Volumn 35, Issue 4, 2007, Pages 479-485

  Logician, Eric L ^a   Ciafaloni, Emma ^a   Quinn, L Christine ^a   Dilek, Nuran ^a   Pandya, Shree ^a   Moxley III, Richard T ^a   Thornton, Charles A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Electrical myotonia; Myotonia; Myotonic discharges; Myotonic dystrophy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; ELECTROMYOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUSCLE TISSUE; MUSCLE WEAKNESS; MYOTONIA; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 1; MYOTONIC DYSTROPHY TYPE 2; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ACTION POTENTIALS; ADULT; AGED; ARM; DIAGNOSIS, DIFFERENTIAL; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; FEMALE; HUMANS; LEG; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYOTONIC DYSTROPHY; NEEDLES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 34047219170     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20722     Document Type: Article

References (25)

1. American Association of Electrodiagnostic Medicine. Glossary of terms in electrodiagnostic medicine. Muscle Nerve 2001; 26:S5-S50.
2. Bassez G, Attarian S, Laforet P, Azulay JP, Rouche A, Ferrer X, et al. Proximal myotonial myopathy (PROMM): clinical and histology study. Rev Neurol (Paris) 2001;157:209-218.
3. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy-expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.
4. Charlet B, Savkur RS, Singh G, Philips AV, Grice EA, Cooper TA. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002;10:45-53.
5. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, et al. Myotonic dystrophy type 2-molecular, diagnostic and clinical spectrum. Neurology 2003;60:657-664.
6. Day JW, Roelofs R, Leroy B, Pech I, Benzow K, Ranum LPW. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromuscul Disord 1999;9:19-27.
7. Gonzalez I, Ohsawa N, Singer RH, Devillers M, Ashizawa T, Balasubramanyam A, et al. New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). Neurology 2000;54:1218-1221.
8. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001;293:864-867.
9. Logigian EL, Moxley RT, Blood CL, Barbieri CA, Martens WB, Wiegner AW, et al. Leukocyte CTG repeat length correlates with severity of myotonia in myotonic dystrophy type 1. Neurology 2004;62:1081-1089.
10. Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 2005;32:1-18.
11. Mankodi A, Takahashi MP, Jiang H, Beck CL, Bowers WJ, Moxley RT, et al. Expanded CUG repeats trigger aberrant splicing of CIC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 2002;10:35-44.
12. Mankodi A, Teng-Umnuay P, Krym M, Henderson D, Swanson M, Thornton CA. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann Neurol 2003;54:760-768.
13. Personius KE, Pandya S, King WM, Tawil R, McDermott MP. Facioscapulohumeral dystrophy natural history study-standardization of testing procedures and reliability of measurements. Phys Ther 1994;74:253-263.
14. Pfeilsticker BHM, Bertuzzo CS, Nucci A. Electrophysiological evaluation in myotonic dystrophy-correlation with CTG length expansion. Arq Neuropsiquiatr 2001;59:186-191.
15. Ranum LPW, Rasmussen PF, Benzow KA, Koob MD, Day JW. Genetic mapping of a second myotonic dystrophy locus. Nat Genet 1998;19:196-198.
16. Ricker K. Myotonic dystrophy and proximal myotonic myopathy. J Neurol 1999;246:334-338.
17. Ricker K, Koch MC, Lehmann-Horn F, Pongratz D, Otto M, Heine R, et al. Proximal myotonic myopathy-a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 1994;44:1448-1452.
18. Ricker K, Koch MC, Lehmann-Horn F, Pongratz D, Speich N, Reiners K, et al. Proximal myotonic myopathy-clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 1995;52:25-31.
19. Sander HW, Scelsa SN, Conigliari MF, Chokroverty S. The short exercise test is normal in proximal myotonic myopathy. Clin Neurophysiol 2000;111:362-366.
20. Sander HW, Tavoulareas GP, Chokroverty S. Heat-sensitive myotonia in proximal myotonic myopathy. Neurology 1996; 47:956-962.
21. Streib E, Sun SF. Electromyography in myotonic dystrophy. Ann Neurol 1983;13:218-219.
22. The FSH-DY Group. A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. Neurology 2006; 48:38-46.
23. Thornton CA, Griggs RC, Moxley RT. Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 1994;35: 269-272.
24. Thornton CA, Johnson K, Moxley RT. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol 1994;35:104-107.
25. Udd B, Krahe R, Wallgren-Pettersson C, Falck B, Kalimo H. Proximal myotonic dystrophy-a family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: heterogeneity of proximal myotonic syndromes? Neuromuscul Disord 1997;7:217-228.